WAINZUA sol inj 45 mg/0.8ml stylo pré 0.8 ml

7680693320017 CH-69332 N07XX21 01.99.0.

Reimbursement limitations:

WAINZUA.01

Avant de pouvoir initier le traitement, le patient doit être informé par écrit des critères …

WAINZUA sol inj 45 mg/0.8ml stylo pré 0.8 ml
WAINZUA sol inj 45 mg/0.8ml stylo pré 0.8 ml
WAINZUA sol inj 45 mg/0.8ml stylo pré 0.8 ml
1 / 3
google

Details

Product number
6933201
CPT
-
Packaging group
1
Unit
Einzeldose(n)
Composition
Lösung: eplontersenum 56 mg/ml, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, natrium < 1 mmol Natrium (23 mg), 1 ml corresp..

Articles (1)

WAINZUA, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/05/2025
Patient information leaflet
Français
29/05/2025
Patient information leaflet
Italien
29/05/2025
Professional SmPC
Allemand
29/05/2025
Professional SmPC
Français
29/05/2025
Professional SmPC
Italien
29/05/2025

Detailed composition

Substance Quantity Type Category
SOLU
56.0 MGML Substance Wirkstoff (Principe actif)
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HBESI

Reimbursement information

Public price
CHF 31809.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
69332
Drug name
WAINZUA, Injektionslösung
Galenic form
INLFP
ATC Code
N07XX21
Authorization status
Z
Dispensation category
B
First authorization
14/02/2025
Authorization expiration date
13/02/2030
IT number
01.99.0.
Domain
Human medicine
Field of application
Wainzua wird angewendet zur Behandlung erwachsener Patienten mit Polyneuropathie im Stadium 1 und 2 im Zusammenhang mit hereditärer Transthyretin-vermittelter Amyloidose (ATTRv).

Packaging details

Description (FR)
WAINZUA sol inj 45 mg/0.8ml stylo pré 0.8 ml
Description (DE)
WAINZUA Inj Lös 45 mg/0.8ml Fertpen 0.8 ml
Market launch
14/02/2025
Narcotic (BTM)
No

Application methods

SUBC